Aldeyra Therapeutics, Inc. (ALDX)
1.595
-0.08
(-5.06%)
USD |
NASDAQ |
May 18, 16:00
1.595
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Research and Development Expense (Quarterly) : 2.410M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 364.87M |
| AbbVie, Inc. | 2.472B |
| Rhythm Pharmaceuticals, Inc. | 41.67M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| ADMA Biologics, Inc. | 2.597M |